Dr Eckfeldt on the Treatment Paradigm and Current Challenges in MDSByCraig Eckfeldt, MD, PhDJanuary 9th 2025Craig Eckfeldt, MD, PhD, discusses the current treatment paradigm in MDS and the unmet needs in different subsets of patients.
Dr Eckfeldt on the Implications of Improved MRD Testing in AMLByCraig Eckfeldt, MD, PhDJuly 19th 2024Craig Eckfeldt, MD, PhD, discusses how improved minimal residual disease testing methods have impacted the acute myeloid leukemia treatment paradigm.